459 related articles for article (PubMed ID: 30724018)
21. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
[TBL] [Abstract][Full Text] [Related]
23. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
24. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
[TBL] [Abstract][Full Text] [Related]
25. Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.
Buszman PE; Buszman PP; Banasiewicz-Szkróbka I; Milewski KP; Żurakowski A; Orlik B; Konkolewska M; Trela B; Janas A; Martin JL; Kiesz RS; Bochenek A
JACC Cardiovasc Interv; 2016 Feb; 9(4):318-327. PubMed ID: 26892080
[TBL] [Abstract][Full Text] [Related]
26. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.
Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S
JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597
[TBL] [Abstract][Full Text] [Related]
27. Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
Takagi H; Ando T; Umemoto T;
Catheter Cardiovasc Interv; 2018 Mar; 91(4):697-709. PubMed ID: 28799701
[TBL] [Abstract][Full Text] [Related]
28. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials.
Putzu A; Gallo M; Martino EA; Ferrari E; Pedrazzini G; Moccetti T; Cassina T
Int J Cardiol; 2017 Aug; 241():142-148. PubMed ID: 28438354
[TBL] [Abstract][Full Text] [Related]
29. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis.
De Rosa S; Polimeni A; Sabatino J; Indolfi C
BMC Cardiovasc Disord; 2017 Sep; 17(1):240. PubMed ID: 28877676
[TBL] [Abstract][Full Text] [Related]
31. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
32. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park SW; Serruys PW; Park SJ
Catheter Cardiovasc Interv; 2017 Aug; 90(2):177-185. PubMed ID: 28112467
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients.
Alam M; Huang HD; Shahzad SA; Kar B; Virani SS; Rogers PA; Paniagua D; Bozkurt B; Palacios I; Kleiman NS; Jneid H
Circ J; 2013; 77(2):372-82. PubMed ID: 23123552
[TBL] [Abstract][Full Text] [Related]
34. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
[TBL] [Abstract][Full Text] [Related]
36. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
37. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
38. Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis.
Ariyaratne TV; Ademi Z; Yap CH; Billah B; Rosenfeldt F; Yan BP; Reid CM
Int J Cardiol; 2014 Sep; 176(2):346-53. PubMed ID: 25127976
[TBL] [Abstract][Full Text] [Related]
39. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.
Giustino G; Serruys PW; Sabik JF; Mehran R; Maehara A; Puskas JD; Simonton CA; Lembo NJ; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Ragosta M; Kron IL; Liu Y; Zhang Z; McAndrew T; Dressler O; Généreux P; Ben-Yehuda O; Pocock SJ; Kappetein AP; Stone GW
JACC Cardiovasc Interv; 2020 Feb; 13(3):375-387. PubMed ID: 31954680
[TBL] [Abstract][Full Text] [Related]
40. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
